Low TLR9 expression has been linked to an aggressive subtype of triple-negative breast cancer and poor disease-specific survival in patients with triple-negative breast cancer, indicating that TLR9 expression is favorable for the patient prognosis with this type of breast cancer (80). This evidence concerns the gene TLR9 and breast cancer.